Location, location, location: the BRMS1 protein and melanoma progression

BMC Medicine

Rajeev S Samant²  Adam I Riker¹ 

[1] Advocate Christ Medical Center, Advocate Cancer Institute, Oak Lawn, IL, USA;Department Oncologic Sciences, Mitchell Cancer Institute, University South Alabama, Mobile, AL, USA

关键词: tumor suppressor;    metastasis;    melanoma;    BRMS1;   

Others  :  1126404
DOI  :  10.1186/1741-7015-10-19

 received in 2012-01-23, accepted in 2012-02-22,  发布年份 2012

【 摘 要 】

The metastasis suppressor, BRMS1, has been demonstrated to cause dramatic regression of metastatic lesions without blocking orthotopic tumor growth. The role of BRMS1 is well-documented for several non-melanoma malignancies, such as breast cancer, ovarian cancer and non-small-cell lung cancer. However, its role in melanoma is just beginning to be understood, with a recent article by Slipicevic et al. highlighting the levels of expression of BRMS1 in benign nevi, primary and metastatic melanoma samples. Their findings emphasize that the intracellular location of BRMS1 protein (cytoplasmic or nuclear), appears to have a significant impact upon the metastatic capacity of melanoma cells. Interestingly, this selective localization translates into a statistically significant decrease in the relapse-free period in melanoma patients, further associated with a thicker Breslow's depth of primary melanomas. However, and more importantly, this study begins to define a clearer role for BRMS1 in melanoma that is strictly dependent upon its cellular location, with nuclear expression associated with invasive and metastatic capacity and cytoplasmic expression resulting in repressive effects upon progression and metastasis.

Please see related article: http://www.biomedcentral.com/1471-2407/12/73 webcite

【 授权许可】

   
2012 Riker and Samant; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Samant RS, Seraj MJ, Saunders MM, Sakamaki TS, Shevde LA, Harms JF, Leonard TO, Goldberg SF, Budgeon L, Meehan WJ, Winter CR, Christensen ND, Verderame MF, Donahue HJ, Welch DR: Analysis of mechanisms underlying BRMS1 suppression of metastasis. Clin Exp Metastasis 2000, 18:683-693.
• [2]Seraj MJ, Samant RS, Verderame MF, Welch DR: Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. Cancer Res 2000, 60:2764-2769.
• [3]Shevde LA, Samant RS, Goldberg SF, Sikaneta T, Alessandrini A, Donahue HJ, Mauger DT, Welch DR: Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1. Exp Cell Res 2002, 273:229-239.
• [4]Cicek M, Fukuyama R, Welch DR, Sizemore N, Casey G: Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity. Cancer Res 2005, 65:3586-3595.
• [5]Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, Welch DR: Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res 2009, 69:1279-1283.
• [6]Liu Y, Smith PW, Jones DR: Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis. Mol Cell Biol 2006, 26:8683-8696.
• [7]Samant RS, Clark DW, Fillmore RA, Cicek M, Metge BJ, Chandramouli KH, Chambers AF, Casey G, Welch DR, Shevde LA: Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation. Mol Cancer 2007, 6:6. BioMed Central Full Text
• [8]Saunders MM, Seraj MJ, Li Z, Zhou Z, Winter CR, Welch DR, Donahue HJ: Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. Cancer Res 2001, 61:1765-1767.
• [9]Edmonds MD, Hurst DR, Vaidya KS, Stafford LJ, Chen D, Welch DR: Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression. Int J Cancer 2009, 125:1778-1785.
• [10]Hurst DR, Xie Y, Vaidya KS, Mehta A, Moore BP, Accavitti-Loper MA, Samant RS, Saxena R, Silveira AC, Welch DR: Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells. J Biol Chem 2008, 283:7438-7444.
• [11]Meehan WJ, Samant RS, Hopper JE, Carrozza MJ, Shevde LA, Workman JL, Eckert KA, Verderame MF, Welch DR: Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription. J Biol Chem 2004, 279:1562-1569.
• [12]Liu Y, Mayo MW, Nagji AS, Smith PW, Ramsey CS, Li D, Jones DR: Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1. Oncogene 2011, in press.
• [13]Metge BJ, Liu S, Riker AI, Fodstad O, Samant RS, Shevde LA: Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1. Oncology 2010, 78:75-86.
• [14]O'Brate A, Giannakakou P: The importance of p53 location: nuclear or cytoplasmic zip code? Drug Resist Updat 2003, 6:313-322.
• [15]Zhao Y, Chaiswing L, Velez JM, Batinic-Haberle I, Colburn NH, Oberley TD, St Clair DK: p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase. Cancer Res 2005, 65:3745-3750.
• [16]Rivera J, Megias D, Navas C, Bravo J: Identification of essential sequences for cellular localization in BRMS1 metastasis suppressor. PLoS One 2009, 4:e6433.
• [17]Hurst DR, Xie Y, Edmonds MD, Welch DR: Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model. Clin Exp Metastasis 2009, 26:89-96.
• [18]Li J, Li G: Cell cycle regulator ING4 is a suppressor of melanoma angiogenesis that is regulated by the metastasis suppressor BRMS1. Cancer Res 2010, 70:10445-10453.
• [19]Li J, Cheng Y, Tai D, Martinka M, Welch DR, Li G: Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis. Oncogene 2011, 30:896-906.